Sarah Chapman

Sarah Chapman is currently the Director of Corporate Strategy at Dextera Biosciences. Previously, Sarah worked as a Biopharmaceutical Strategy Consultant at Chapman Biomedical Consulting Ltd. and as a Consultant at ClearView Healthcare Partners, focusing on strategy consulting for life sciences companies. Sarah also has experience in academic research at Harvard University and the Karolinska Institutet Department of Cell and Molecular Biology. Sarah holds a Bachelor's Degree in Human Developmental and Regenerative Biology from Harvard University, graduating Summa Cum Laude.